INNOVATIVE APPROACH TO THE DIAGNOSIS OF GROWTH HORMONE INSUFFICIENCY USING GROWTH HORMONE SECRETAGOGUES

被引:0
|
作者
Bercu, Barry B. [1 ]
Walker, Richard F. [2 ]
机构
[1] Univ S Florida, Morsani Coll Med, Tampa, FL USA
[2] BioSciences LLC, Clearwater, FL USA
关键词
Diagnostic test; Growth hormone releasing hormone (GHRH); Ghrelin; Hypothalamic-pituitary function; Growth hormone deficiency and insufficiency; Aging;
D O I
10.3727/194982412X13500042168893
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The diagnosis of growth hormone (GH) insufficiency has been a diagnostic dilemma for many decades. Over the years, we have developed rodent and nonhuman primate models to address this clinical challenge in children and adults, including the adult aging population. Deficits in GH secretion can be attributed to pituitary and/or hypothalamic ideologies with the most common cause (especially in children and aging adults) being insufficient production and/or secretion of neuroregulatory hormones [GH releasing hormone (GHRH) and ghrelin]. Here we present a patented innovative three-step provocative test as an improvement over traditional provocative testing. This diagnostic approach better addresses the physiologic neuroregulatory control of GH secretagogues on pituitary function. This sequential and combined stimulation with GHRH and ghrelin mimetics supports the hypothetical model for the complementary relationship of GHRH and ghrelin. Data are presented to support the utility of this diagnostic procedure.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [31] Growth hormone secretagogues: out of competition
    Armand Pinyot
    Zoran Nikolovski
    Jaume Bosch
    Gerard Such-Sanmartín
    Shinji Kageyama
    Jordi Segura
    Ricardo Gutiérrez-Gallego
    Analytical and Bioanalytical Chemistry, 2012, 402 : 1101 - 1108
  • [32] TRIPEPTIDE GROWTH-HORMONE SECRETAGOGUES
    YANG, LH
    NARGUND, RP
    MORIELLO, G
    BARAKAT, K
    PAN, YP
    PRENDERGAST, K
    CHENG, K
    JACKS, T
    CHAN, WWS
    SCHLEIM, KD
    SMITH, RG
    PATCHETT, AA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 11 - MEDI
  • [33] Growth hormone secretagogues in critical illness
    Van den Berghe, G
    HORMONE RESEARCH, 1999, 51 : 21 - 28
  • [34] Growth hormone secretagogues as therapeutic agents
    Svensson, J
    GROWTH HORMONE & IGF RESEARCH, 1999, 9 : 107 - 109
  • [35] Pharmacophore model of growth hormone secretagogues
    Liu, L
    Wang, RX
    Lai, LH
    Li, CX
    PEPTIDES: BIOLOGY AND CHEMISTRY, 2000, : 169 - 171
  • [36] Relative values of recombinant growth hormone and growth hormone secretagogues in clinical practice
    Bercu, BB
    Walker, RF
    ENDOCRINOLOGIST, 2002, 12 (05): : 433 - 444
  • [37] Growth hormone secretagogues and hypothalamic networks
    Marie-Thérèse Bluet-Pajot
    Virginie Tolle
    Philippe Zizzari
    Christophe Robert
    Constance Hammond
    Valérie Mitchell
    Jean-Claude Beauvillain
    Cécile Viollet
    Jacques Epelbaum
    Claude Kordon
    Endocrine, 2001, 14 : 1 - 8
  • [38] Growth hormone secretagogues: out of competition
    Pinyot, Armand
    Nikolovski, Zoran
    Bosch, Jaume
    Such-Sanmartin, Gerard
    Kageyama, Shinji
    Segura, Jordi
    Gutierrez-Gallego, Ricardo
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2012, 402 (03) : 1101 - 1108
  • [39] Clinical use of growth hormone secretagogues
    Bach, MA
    GROWTH HORMONE SECRETAGOGUES IN CLINICAL PRACTICE, 1998, : 305 - 327
  • [40] Modulation of growth hormone secretion through the action of growth hormone secretagogues and ghrelin
    Lengyel, Ana-Maria J.
    Paiva Cunha de Sa, Larissa Bianca
    SALUD I CIENCIA, 2008, 16 (05): : 505 - 508